Antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; pharmaceuticals for the treatment of coronavirus diseases and COVID-19;
REGISTERED
on 05 Apr 2023
REGEN-COV
REGENERON PHARMACEUTICALS INC.
2102416 · 26 Apr 2021
005
Class 005
Pharmaceutical Products
Antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; pharmaceuticals for the treatment of coronavirus diseases and COVID-19;
Antivirals for treatment or prevention of COVID-19, coronavirus diseas...
